Press Releases April 23, 2026 09:48 AM

StoneX Partners with Expana to Offer First of New Suite of OTC Dairy Derivatives

StoneX and Expana launch first OTC dairy derivative contract introducing FFMP pricing to manage dairy price volatility

By Leila Farooq SNEX
StoneX Partners with Expana to Offer First of New Suite of OTC Dairy Derivatives
SNEX

StoneX Financial Europe GmbH, a subsidiary of StoneX Group Inc., has partnered with Expana to launch the Fat Filled Milk Powder (FFMP) contract, the first in a new suite of OTC dairy derivatives. This product leverages Expana's IOSCO Assured EU dairy benchmark prices to offer a trusted price mechanism for FFMP, enabling market participants to hedge against volatile dairy prices. Additional products are in development to expand this offering, providing clients better tools to manage dairy market risks through integrated trading platforms.

Key Points

  • StoneX has introduced the first OTC dairy derivative contract for Fat Filled Milk Powder (FFMP) in partnership with Expana.
  • The product uses Expana's IOSCO Assured EU dairy benchmark prices, enhancing price transparency and trust in a volatile dairy commodity market.
  • The partnership aims to expand the suite of dairy derivatives, providing clients with improved risk management tools within existing StoneX trading workflows.

LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- StoneX Financial Europe GmbH ("SFEG"), a subsidiary of StoneX Group Inc. (“StoneX”; NASDAQ: SNEX), today announced the launch of Fat Filled Milk Powder (FFMP), the first contract from a new OTC dairy derivatives suite developed in partnership with global agri-food intelligence platform, Expana, underpinned by their IOSCO Assured EU dairy benchmark prices.

“This product delivers a price for FFMP that every participant in the market can trust, regardless of which side of the trade they are on and delivers…”
“This announcement marks a strong foundation for our partnership with Expana, and with additional products already in development, this is just the beginning…”
“This product delivers a price for FFMP that every participant in the market can trust, regardless of which side of the trade they are on and delivers…”
“This announcement marks a strong foundation for our partnership with Expana, and with additional products already in development, this is just the beginning…”
“This product delivers a price for FFMP that every participant in the market can trust, regardless of which side of the trade they are on and delivers…”

The global dairy industry operates on volatile, interconnected commodity pricing which can shift sharply without warning. For many dairy products, participants have had no direct way to hedge their exposure. Historically, risk was absorbed, managed around, or passed down the chain.

The StoneX–Expana partnership expands the range of tools available to clients for managing dairy price volatility. The first contract is now tradeable, with coverage set to expand across additional dairy products over time.

StoneX customers can access the contracts within their existing trading workflow and can also use StoneX Plus to view and analyse historical FFMP prices and other selected Expana Dairy Benchmarks.

Liam Fenton, Global Head of Dairy & Food Group at StoneX, said:

“This announcement marks a strong foundation for our partnership with Expana, and with additional products already in development, this is just the beginning of a broader collaboration. The introduction of this new suite of OTC dairy derivatives responds directly to our clients' needs of having direct insights to their risk profiles in an increasingly volatile market.”

Marcel Goldenberg, Co-Chief Market Reporting Officer at Expana, commented:

"This product delivers a price for FFMP that every participant in the market can trust, regardless of which side of the trade they are on and delivers arbitrage opportunities against Skimmed Milk Powder and Vegetable Oils that were previously not available."

About Expana:

Expana is the world’s leading agrifood-focused Price Reporting Agency and global information provider. In markets defined by volatility, opacity and risk, Expana equips organizations with exceptional data to drive better decisions. By uniting frequently updated pricing data, forecasts, cost modeling and expert analysis, Expana transforms market data into boardroom-ready intelligence. The result: optimal choices contributing to reduced risk, savings in COGS, stronger supply resilience, confident growth. For more information on Expana, please visit www.expanamarkets.com.

About StoneX:

StoneX Group Inc., through its subsidiaries, operates a global financial services network that connects companies, organisations, traders, and investors to the global market ecosystem through a unique blend of digital platforms, end-to-end clearing and execution services, high-touch service, and deep expertise. The company strives to be the one trusted partner to its clients, providing its network, products, and services to allow them to pursue trading opportunities, manage their market risks, make investments, and improve their business performance.

A Fortune 50 company headquartered in New York City and listed on the Nasdaq Global Select Market (NASDAQ: SNEX), StoneX Group Inc. and its more than 4,700 employees serve over 54,000 commercial, institutional, and payments clients, as well as more than 260,000 retail accounts, across more than 80 offices on six continents. Further information is available at www.stonex.com.

Business inquiries:

John Lancaster
Head of EMEA Dairy & Food Consulting, StoneX Financial Europe GmbH-Dublin
[email protected]  

Media inquiries:

Dana S. Grosser
Global Head of Corporate Communications
[email protected]
+1 (646) 984-1967

SNEX-G


Risks

  • Market volatility and rapidly changing dairy commodity prices could affect the adoption and pricing of the new OTC derivatives.
  • Dependence on the accuracy and acceptance of Expana's benchmark prices, which if questioned could reduce market confidence.
  • Competition and regulatory risks around OTC derivatives markets might influence product success and compliance costs.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026